China NT Pharma and Hilong raise a combined $342 million

Investors respond well to the Hong Kong IPOs of China NT Pharma and Hilong, helping them to raise a total of $342 million.
China NT Pharma's Suzhou factory
China NT Pharma's Suzhou factory

China NT Pharma Group raised HK$1.62 billion ($208 million) in a Hong Kong IPO last week, while Hilong Holdings pocketed HK$1.04 billion ($134 million) after a failed first attempt.

¬ Haymarket Media Limited. All rights reserved.

Sign In to Your Account To Access Exclusive FinanceAsia Content!

Please sign in to your subscription to unlock full access to our premium FA resources.

Free Registration & 7-Day Trial
Register now to enjoy a 7-day free trial - no registration fees required. Click the link to get started.

Note: This free trial is a one-time offer.

Questions?
If you have any enquiries or would like a quote for a team or company licence, please contact us at [email protected]. Our subscription team will be happy to assist you.

Share our publication on social media
Share our publication on social media